Ashford Capital Management’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.3M | Buy |
1,265,670
+27,830
| +2% | +$445K | 2.38% | 14 |
|
|
2025
Q1 | $24.1M | Sell |
1,237,840
-612,840
| -33% | -$11.9M | 3.1% | 9 |
|
|
2024
Q4 | $40.8M | Sell |
1,850,680
-38,530
| -2% | -$849K | 4.81% | 1 |
|
|
2024
Q3 | $31.8M | Sell |
1,889,210
-15,070
| -0.8% | -$254K | 3.97% | 2 |
|
|
2024
Q2 | $22.8M | Buy |
1,904,280
+63,040
| +3% | +$753K | 3.07% | 12 |
|
|
2024
Q1 | $20.4M | Buy |
1,841,240
+350,140
| +23% | +$3.88M | 2.76% | 14 |
|
|
2023
Q4 | $12.9M | Buy |
+1,491,100
| New | +$12.9M | 1.73% | 24 |
|